Year archive

Inify Laboratories AB — 2026 filings

All 39 regulatory filings released by Inify Laboratories AB (INIFY) in 2026, sourced directly from the official regulator.

39 Filings

2026 Period

2026 filings (39)

Filing	Released	Lang
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-04-29	Swedish
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-04-29	English
Inify Laboratories har tecknat avtal med Region Jämtland Härjedalen för prostatacancerdiagnostik Regulatory Filings	2026-04-24	Swedish
Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics Regulatory Filings	2026-04-24	English
Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics - Attachment: Inify_Agreement_signed_with_Region_Jamtland_Harjedalen.pdf Regulatory Filings	2026-04-24	English
Inify Laboratories har tecknat avtal med Region Jämtland Härjedalen för prostatacancerdiagnostik - Attachment: Inify_Avtal_signerat_med_Region_Jamtland_Harjedalen.pdf Regulatory Filings	2026-04-24	Swedish
Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics Regulatory Filings	2026-04-24	English
Inify Laboratories har tecknat avtal med Region Jämtland Härjedalen för prostatacancerdiagnostik Regulatory Filings	2026-04-24	Swedish
Inify Laboratories - Årsredovisning 2025 - Attachment: Inify Laboratories Årsredovisning 2025.pdf Annual Report FY 2025	2026-04-15	Swedish
Inify Laboratories - Annual Report 2025 - Attachment: Inify Laboratories Annual Report 2025.pdf Annual Report FY 2025	2026-04-15	English
Inify Laboratories - Årsredovisning 2025 Report Publication Announcement	2026-04-15	Swedish
Inify Laboratories - Annual Report 2025 Report Publication Announcement	2026-04-15	English
Inify Laboratories - kallelse till årsstämma den 20 maj 2026 - Attachment: Inify_Laboratories_kallelse_bolagsstamma_2026_05_20.pdf Proxy Solicitation & Information Statement	2026-04-15	Swedish
Inify Laboratories - notice of Annual General Meeting on May 20, 2026 - Attachment: Inify_Laboratories_AGM_invitation_May_20_2026.pdf Proxy Solicitation & Information Statement	2026-04-15	English
Inify Laboratories - kallelse till årsstämma den 20 maj 2026 Proxy Solicitation & Information Statement	2026-04-15	Swedish
Inify Laboratories - notice of Annual General Meeting on May 20, 2026 Proxy Solicitation & Information Statement	2026-04-15	English
Inify Laboratories – notice of Annual General Meeting on May 20, 2026 AGM Information	2026-04-15	English
Inify Laboratories – kallelse till årsstämma den 20 maj 2026 Proxy Solicitation & Information Statement	2026-04-15	Swedish
Inify Laboratories - New share capital registered - Attachment: Inify_Laboratories_New_share_capital_registered.pdf Share Issue/Capital Change	2026-03-24	English
Inify Laboratories – New share capital registered Share Issue/Capital Change	2026-03-24	English
Inify Laboratories - New share capital registered Share Issue/Capital Change	2026-03-24	English
Inify Laboratories: Solid topplinjevekst, sterk fremdrift i Storbritannia og positiv respons på mage- og tarmdiagnostikk - Attachment: Inify_Laboratories_year_end_report_2025.pdf Interim / Quarterly Report Q4 2025	2026-02-25	English
Inify Laboratories: Solid topplinjevekst, sterk fremdrift i Storbritannia og positiv respons på mage- og tarmdiagnostikk Earnings Release Q4 2025	2026-02-25	Norwegian
Inify Laboratories: Stabil försäljningstillväxt, stark utveckling i Storbritannien och positiv respons på gastrointestinal diagnostik - Attachment: Inify_Laboratories_Bokslutskommunike_Q4_2025.pdf Interim / Quarterly Report Q4 2025	2026-02-25	Swedish
Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics - Attachment: Inify_Laboratories_year_end_report_2025.pdf Interim / Quarterly Report Q4 2025	2026-02-25	English
Inify Laboratories: Stabil försäljningstillväxt, stark utveckling i Storbritannien och positiv respons på gastrointestinal diagnostik Earnings Release Q4 2025	2026-02-25	Swedish
Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics Earnings Release Q4 2025	2026-02-25	English
Correction: Inify Laboratories - mandatory notification of trade Director's Dealing	2026-01-30	English
Correction: Inify Laboratories - mandatory notification of trade - Attachment: Inify_Laboratories_PDMR_attachment_corrected_.pdf Director's Dealing	2026-01-30	English
Correction: Inify Laboratories - mandatory notification of trade Director's Dealing	2026-01-30	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2026-01-27	English
Inify Laboratories - mandatory notification of trade - Attachment: Inify_Laboratories_PDMR_attachment.pdf Director's Dealing	2026-01-27	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2026-01-27	English
Inify Laboratories – Final Results of the Repair Issue Share Issue/Capital Change	2026-01-27	English
Inify Laboratories - Final Results of the Repair Issue - Attachment: Inify_Laboratories_Final_results_of_the_Repair_Issue.pdf Share Issue/Capital Change	2026-01-27	English
Inify Laboratories - Final Results of the Repair Issue Share Issue/Capital Change	2026-01-27	English
Inify Laboratories - Commencement of subscription period for Repair Issue - Attachment: Inify_Laboratories_Commencement_of_subscr_period_for_Repair_Issue.pdf Share Issue/Capital Change	2026-01-12	English
Inify Laboratories - Commencement of subscription period for Repair Issue Share Issue/Capital Change	2026-01-12	English
Inify Laboratories – Commencement of subscription period for Repair Issue Share Issue/Capital Change	2026-01-12	English